195 related articles for article (PubMed ID: 21242331)
1. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):501-8. PubMed ID: 21242331
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
3. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
4. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen].
Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904
[TBL] [Abstract][Full Text] [Related]
5. The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
Urology; 2011 Jan; 77(1):137-41. PubMed ID: 21094992
[TBL] [Abstract][Full Text] [Related]
6. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
[TBL] [Abstract][Full Text] [Related]
7. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
Zhang J; Ma M; Nan X; Sheng B
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
[TBL] [Abstract][Full Text] [Related]
8. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
9. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
10. Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population.
Pater LE; Hart KW; Blonigen BJ; Lindsell CJ; Barrett WL
Am J Clin Oncol; 2012 Oct; 35(5):490-2. PubMed ID: 21577087
[TBL] [Abstract][Full Text] [Related]
11. Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in Japan.
Kubota Y; Seike K; Maeda S; Shinohara Y; Iwata M; Sugimoto N
Int J Urol; 2011 Jan; 18(1):72-5. PubMed ID: 21198939
[TBL] [Abstract][Full Text] [Related]
12. Obesity and prostate cancer detection: insights from three national surveys.
Parekh N; Lin Y; Dipaola RS; Marcella S; Lu-Yao G
Am J Med; 2010 Sep; 123(9):829-35. PubMed ID: 20800152
[TBL] [Abstract][Full Text] [Related]
13. Obesity and prostate cancer screening among African-American and Caucasian men.
Fowke JH; Signorello LB; Underwood W; Ukoli FA; Blot WJ
Prostate; 2006 Sep; 66(13):1371-80. PubMed ID: 16752375
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.
Kryvenko ON; Diaz M; Matoso A; Kates M; Cohen J; Swanson GP; Epstein JI
Urology; 2016 Apr; 90():141-7. PubMed ID: 26773349
[TBL] [Abstract][Full Text] [Related]
15. Body mass index in relation to prostate-specific antigen-related parameters.
Lin D; Liu T; Chen L; Chen Z
BMC Urol; 2021 Sep; 21(1):130. PubMed ID: 34530776
[TBL] [Abstract][Full Text] [Related]
16. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
[TBL] [Abstract][Full Text] [Related]
18. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
[TBL] [Abstract][Full Text] [Related]
19. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
20. Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.
Zhao S; Xia M; Tang J; Yan Y
BJU Int; 2017 Oct; 120(4):482-489. PubMed ID: 27489082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
